Related Experiment Video
Updated: Aug 16, 2026

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA
Published on: December 15, 2023
Clinical and virological differences between hepatitis B virus genotypes B and C: a case-control study
Pisit Tangkijvanich1, Varocha Mahachai, Piyawat Komolmit
1Department of Biochemistry, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand.
Insights
Hepatitis B virus (HBV) genotype C is linked to higher rates of Hepatitis B e antigen (HBeAg) and more severe liver disease compared to genotype B in chronically infected patients.
Area of Science:
- Hepatology
- Virology
- Infectious Diseases
Background:
- The clinical significance of different hepatitis B virus (HBV) genotypes remains incompletely understood.
- Chronic HBV infection affects millions globally, with varying clinical outcomes.
- Genotypes B and C are prevalent in Asia, but their distinct pathogenic roles require further clarification.
Purpose of the Study:
- To investigate and compare the clinical and virological characteristics of HBV genotypes B and C.
- To determine if specific HBV genotypes are associated with different disease severities or progression patterns.
- To elucidate the pathogenic significance of HBV genotypes in a Thai chronic hepatitis B cohort.
Main Methods:
- A case-control study was conducted involving 470 patients with chronic hepatitis B.
- HBV genotyping was performed using polymerase chain reaction (PCR) and restriction fragment length polymorphism (RFLP).
- Sixty-five patients with HBV genotype B were matched with genotype C patients based on sex, age, and liver disease distribution.
Main Results:
- Patients with HBV genotype C exhibited significantly higher serum alanine aminotransferase (ALT) levels compared to genotype B.
- Hepatitis B e antigen (HBeAg) positivity was significantly more frequent in genotype C (50.8%) than genotype B (30.8%) patients.
- HBV DNA levels were comparable between genotypes, but HBeAg-positive genotype C patients were older on average.
Conclusions:
- HBV genotype C is associated with a higher prevalence of HBeAg and delayed HBeAg seroconversion.
- Patients with HBV genotype C demonstrated more severe liver disease progression compared to those with genotype B.
- These findings highlight distinct pathogenic roles for HBV genotypes B and C in chronic infection.
Objective:
The pathogenic significance of hepatitis B virus (HBV) genotypes is undefined. The aim of this study was to elucidate the differences in clinical and virologicalfeatures between HBV genotypes B and C by conducting a case-control study in Thai patients who were chronically infected with the virus.
Patients And Method:
HBV genotyping was assessed by polymerase chain reaction (PCR) and restriction fragment length polymorphism (RFLP) method in stored sera of 470 patients with chronic hepatitis B. Among these, 65 patients with HBV genotype B were enrolled and matched individually to those with HBV genotype C according to sex, age, and distribution of liver disease which included asymptomatic carrier, chronic hepatitis, cirrhosis and hepatocellular carcinoma.
Results:
Serum alanine aminotransferase (ALT) was significantly higher in patients with genotype C than those with genotype B. Hepatitis B e antigen (HBeAg) was significantly more frequent in genotype C than genotype B patients (50.8 and 30.8%, respectively, p=0.03), but the levels of HBV DNA were comparable between them. Among patients who were positive for HBeAg, the mean age of genotype C patients tended to be older than genotype B patients.
Conclusion:
The present study demonstrated that patients with HBV genotype C had a significantly higher rate of HBeAg, experienced delayed HBeAg seroconversion and exhibited more severe liver disease compared to those with genotype B.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Genital Herpes
Human Virome
Cytomegalovirus Disease
